Condition: Mitral Regurgitation · Mitral Valve Disease · Mitral Valve Insufficiency · Sponsor: NeoChord
The objective of this study is to evaluate the 5-year outcomes of participants with degenerative mitral valve disease treated with the NeoChord Artificial Chordae System, Model DS1000 in a post-market setting.
This description comes directly from the study's public registry record.
Alexandar Jonkers · +31 610740977 · ajonkers@neochord.com
Always discuss trial participation with your own doctor first.
| University of Bonn | Bonn, Germany | Recruiting |
| CVC Frankfurt | Frankfurt, Germany | Recruiting |
| University of Mainz | Mainz, Germany | Recruiting |
| Hippokration Hospital | Athens, Greece | Recruiting |
| Triemli Hospital | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04190602